- Home
- GCV vs ASRT Comparison
GCV vs ASRT Comparison
Compare GCV & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- ASRT
- Stock Information
- Founded
- GCV 1988
- ASRT 1995
- Country
- GCV United States
- ASRT United States
- Employees
- GCV N/A
- ASRT N/A
- Industry
- GCV Finance/Investors Services
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- GCV Finance
- ASRT Health Care
- Exchange
- GCV Nasdaq
- ASRT Nasdaq
- Market Cap
- GCV 75.6M
- ASRT 78.3M
- IPO Year
- GCV N/A
- ASRT 1997
- Fundamental
- Price
- GCV $3.80
- ASRT $0.69
- Analyst Decision
- GCV
- ASRT Strong Buy
- Analyst Count
- GCV 0
- ASRT 3
- Target Price
- GCV N/A
- ASRT $3.08
- AVG Volume (30 Days)
- GCV 57.9K
- ASRT 411.3K
- Earning Date
- GCV 01-01-0001
- ASRT 03-12-2025
- Dividend Yield
- GCV 13.04%
- ASRT N/A
- EPS Growth
- GCV N/A
- ASRT N/A
- EPS
- GCV N/A
- ASRT N/A
- Revenue
- GCV N/A
- ASRT $124,961,000.00
- Revenue This Year
- GCV N/A
- ASRT $0.96
- Revenue Next Year
- GCV N/A
- ASRT $12.72
- P/E Ratio
- GCV N/A
- ASRT N/A
- Revenue Growth
- GCV N/A
- ASRT N/A
- 52 Week Low
- GCV $3.15
- ASRT $0.68
- 52 Week High
- GCV $4.58
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- GCV 47.01
- ASRT 36.18
- Support Level
- GCV $3.72
- ASRT $0.70
- Resistance Level
- GCV $3.86
- ASRT $0.75
- Average True Range (ATR)
- GCV 0.08
- ASRT 0.05
- MACD
- GCV 0.00
- ASRT -0.00
- Stochastic Oscillator
- GCV 47.37
- ASRT 10.12
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.